Mirum Pharmaceuticals to release Phase 3 maralixibat study results

October 11, 2026 5:00 PM

Mirum Pharmaceuticals (NASDAQ: MIRM) announced it will host an investor call on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found